Clinical Trial 35956

Long Beach, CA 90806


Study Summary:

This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild AD.


Qualified Participants Must:

• Be diagnosed with Alzheimer's disease
• Be between 50 and 85 years of age (Adult, Senior)


Qualified Participants May Receive:

Study-related medical care and investigational drug at no cost and may be compensated for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.